Markets

EARNINGS SUMMARY: Details of Nektar Therapeutics Q3 Earnings Report

(RTTNews) - Below are the earnings highlights for Nektar Therapeutics (NKTR):

-Earnings: -$98.81 million in Q3 vs. -$96.14 million in the same period last year. -EPS: -$0.56 in Q3 vs. -$0.56 in the same period last year. -Analysts projected -$0.73 per share -Revenue: $29.22 million in Q3 vs. $27.76 million in the same period last year.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

NKTR